The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Yerel katalogda bu makaleye atıf yapan 14 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2023 Cardiovascular manifestations of monogenic periodic fever syndromesAtıf 11 · OpenAlex
2. 2024 Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)Atıf 10 · OpenAlex
3. 2024 Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)Atıf 9 · OpenAlex
4. 2025 International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disordersAtıf 3 · OpenAlex
5. 2025 Mevalonate kinase deficiency in a familial Mediterranean fever endemic region: a single-center experienceAtıf 2 · OpenAlex
6. 2025 Mevalonate kinase deficiency in a familial Mediterranean fever endemic region: a single-center experienceAtıf 2 · OpenAlex
7. 2024 Adverse events of biological agents in pediatric rheumatologic diseasesAtıf 1 · OpenAlex
8. 2024 Adverse events of biological agents in pediatric rheumatologic diseasesAtıf 1 · OpenAlex
9. 2024 Adverse events of biological agents in pediatric rheumatologic diseasesAtıf 1 · OpenAlex
10. 2026 Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseasesAtıf 0 · OpenAlex